Potential Shifts in Section 337 Precedent: What The Data Tells Us

March 11, 2026

ABA White Collar Crime Institute 2026

On March 11, Axinn partner Jacklin Chou Lem will moderate the "Trends and Recent Developments in Criminal Antitrust Enforcement" panel at the American Bar Association's White Collar Crime Institute, being held March 10-13 in San Diego.

Speaking Engagement

March 3, 2026

GCR Live Cartels: 2026

On March 3, Axinn partner Dan Oakes will speak on the "A New Kind of Payday: Whistleblower Program Rewards" panel at Global Competition Review's Cartels Conference in Washington, DC.

Speaking Engagement

Antitrust

February 27, 2026

Noerr Competition Day 2026

On February 27, Axinn partner Dan Oakes will speak on the "A New Age in Cartel Enforcement?" panel at Noerr Competition Day in Munich, Germany.

Speaking Engagement

Antitrust

February 19, 2026

Consumer Brands CPG Legal Forum 2026

On February 19, Axinn partners Jacklin Chou Lem and Matthew Murphy will speak at the Consumer Brands Association’s CPG Legal Forum, being held February 18-20 in Frisco, Texas.

Speaking Engagement

February 19, 2026

NBA CLS 39th Annual Corporate Counsel Conference

Axinn is pleased to sponsor the National Bar Association Commercial Law Section’s 39th Annual Corporate Counsel Conference, being held February 18-21 in Dana Point, California.

Sponsorship

Antitrust

February 19, 2026

University of Pennsylvania Journal of Business Law Annual Symposium 2026

On February 19, Axinn counsel Laura Onken will speak on the "Antitrust & Distribution: Competition in Global Luxury Markets" panel at the University of Pennsylvania's Journal of Business Law Annual Symposium.

Speaking Engagement

Antitrust

February 12, 2026

No More Needles in Haystacks: Congress Requires FDA to Explain Q1/Q2 Sameness

Last week, on February 3, 2026, Congress passed the Consolidated Appropriations Act (“the Act”), providing generic drug manufacturers...

Axinn Viewpoints

Intellectual Property

February 12, 2026

Oliver Twisted Again: After FDA's Court Losses, Congress Approves FDA's Standards on Orphan Drug Exclusivity

Last week, Congress enacted the Consolidated Appropriations Act of 2026. This legislation narrows the scope of the statutory protection...

Axinn Viewpoints

Intellectual Property

February 9, 2026

2025 Healthcare Antitrust Enforcement Wrap Up

On January 28, Axinn hosted a Healthcare Antitrust Year-In-Review CLE webinar, presented by counsel Carol Liu and Monica Smith, and...

Axinn Viewpoints

Antitrust

February 6, 2026

Here We Go Again: Third Round of Inflation Reduction Act Drugs Listed

Pursuant to the Inflation Reduction Act (the “IRA”), the Secretary of Health and Human Services (“HHS”) and the Center for Medicare &...

Axinn Viewpoints

Intellectual Property

February 5, 2026

CLA Antitrust and Consumer Protection Section In-House Counsel Summit

On February 5, Axinn partner Jacklin Chou Lem will speak at the California Lawyers Association Antitrust and Consumer Protection In-House Counsel Summit.

Speaking Engagement

Antitrust

February 5, 2026

New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review

On February 5, Axinn antitrust practice chair Mike Keeley will speak on the "Regulated Markets, Competition and Competitiveness" panel at Concurrences' New Frontiers of Antitrust Conference in Paris.

Speaking Engagement

Antitrust

Potential Shifts in Section 337 Precedent: What The Data Tells Us

Related People

Related Services

Featured Insights

Featured Insights